SynthesisInternal and emergency medicine2017

PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis.

Alessandro Squizzato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.